Loading...
Please wait, while we are loading the content...
Similar Documents
Patterns of Treatment among Bipolar Disorder Patients Treated with Antidepressants
| Content Provider | Semantic Scholar |
|---|---|
| Author | Birnbaum, Hg Mackell, Ja |
| Copyright Year | 2010 |
| Abstract | PPM. These charges averaged about $14 PPM (P = 0.069) and $9 PPM (P = 0.231) lower than those of risperidone and olanzapine, respectively, a savings of 2%–3% based on a $526 PPM mean charge. Differences in nonantipsychotic mental health care charges PPM among bipolar patients treated with risperidone, olanzapine, or quetiapine were largely explained by differing patient and treatment characteristics rather than the antipsychotic used. After dosage levels were standardized, however, olanzapine was associated with significantly higher drug acquisition costs than those of risperidone and quetiapine (57% and 49% respectively; P < 0.01). Although the difference in drug charges between risperidone and quetiapine was not statistically significant, quetiapine was associated with lower PPM resource utilization. CONCLUSION: Quetiapine appears to be associated with modestly lower non-antipsychotic mental health resource use compared to risperidone and olanzapine for treatment of bipolar disorder. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://core.ac.uk/download/pdf/82019191.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Antidepressive Agents Bipolar Disorder Forty Nine Health Care Mental disorders Patients Risperidone olanzapine part per million (ppm) quetiapine |
| Content Type | Text |
| Resource Type | Article |
